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Background/aims
Variations in the treatment of Juvenile Idiopathic
Arthritis (JIA) may impact on quality of care. The objec-
tive of this study was to identify and compare treatment
approaches for JIA in two health care systems.
Methods
Pediatric Rheumatologists in Canada (n=58) and Ger-
many/Austria (n=172) were surveyed by email, using
case-based vignettes for oligoarthritis and seronegative
polyarthritis. Data was analyzed using descriptive statis-
tics; responses were compared using univariate analysis.
Results
Total response rate was 63%. Physicians were compar-
able by age, level of training and duration of practice,
but more Canadians were based in academic centers.
German physicians were more likely to institute
DMARD treatment in oligoarthritis refractory to NSAID
(p<0.001), and oral steroid treatment in uveitis
(p=0.043). Canadian physicians were more likely to
switch to a different DMARD rather than a biologic
agent in polyarthritis refractory to DMARD. Both physi-
cian groups agreed on time to judge effectiveness of
DMARDs (mean 4.2 months) and time to switch to bio-
logic treatment (mean 5.4 months). 86% and 90% of
German physicians preferred regular physiotherapy over
home exercise compared to 14% and 15% in Canada for
oligoarthritis and polyarthritis, respectively. Except for a
Canadian preference for Napr o x e ni no l i g o a r t h r i t i s ,n o
significant differences were found for NSAID,
intraarticular steroid preparations, initial DMARD and
initial biologic treatment.
Conclusion
Treatment of oligo- and polyarticular JIA with DMARD
follows established guidelines, while usage of intraarticu-
lar steroids and biologic agents is variable within and
between physician groups. Physiotherapy has a funda-
mentally different role in the two health care systems.
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